These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31748582)

  • 21. Incidence of malignancy and related mortality after kidney transplantation: a nationwide, population-based cohort study in Korea.
    Jeong S; Lee HS; Kong SG; Kim DJ; Lee S; Park MJ; Song W; Rim JH; Kim HJ
    Sci Rep; 2020 Dec; 10(1):21398. PubMed ID: 33293655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of malignant neoplasms after liver transplantation: a population-based study.
    Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
    Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014.
    Taborelli M; Piselli P; Ettorre GM; Lauro A; Galatioto L; Baccarani U; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Sforza D; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Burra P; Rossi M; Tisone G; Zamboni F; Serraino D;
    Int J Cancer; 2018 Oct; 143(7):1588-1594. PubMed ID: 29693248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.
    Baccarani U; Piselli P; Serraino D; Adani GL; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; De Paoli A; Cimaglia C; Bresadola V; Toniutto P; Risaliti A; Cillo U; Bresadola F; Burra P
    Dig Liver Dis; 2010 Jan; 42(1):55-60. PubMed ID: 19497797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
    Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
    Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo malignancies following liver transplantation: results from a multicentric study in central and southern Italy, 1990-2008.
    Ettorre GM; Piselli P; Galatioto L; Rendina M; Nudo F; Sforza D; Miglioresi L; Fantola G; Cimaglia C; Vennarecci G; Vizzini GB; Di Leo A; Rossi M; Tisone G; Zamboni F; Santoro R; Agresta A; Puro V; Serraino D
    Transplant Proc; 2013 Sep; 45(7):2729-32. PubMed ID: 24034034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer After Liver Transplantation in Children and Young Adults: A Population-Based Study From 4 Nordic Countries.
    Åberg F; Isoniemi H; Pukkala E; Jalanko H; Rasmussen A; Storm HH; Schultz N; Bennet W; Ekvall N; Ericzon BG; Malenicka S; Tretli S; Line PD; Boberg KM; Østensen A; Karlsen TH; Nordin A
    Liver Transpl; 2018 Sep; 24(9):1252-1259. PubMed ID: 30120902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
    Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
    PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.
    Na R; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Am J Transplant; 2013 Jan; 13(1):174-83. PubMed ID: 23094788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group.
    O'Neill JP; Sexton DJ; O'Leary E; O'Kelly P; Murray S; Deady S; Daly F; Williams Y; Dean B; Fitzgerald C; Murad A; Mansoor N; O'Neill JO; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Little D; Moloney FJ; Conlon PJ
    Clin Transplant; 2019 Oct; 33(10):e13669. PubMed ID: 31310037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study.
    Pedersen SB; Nielsen JC; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT
    Europace; 2015 Jun; 17(6):902-8. PubMed ID: 25840286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
    Francis A; Johnson DW; Teixeira-Pinto A; Craig JC; Wong G
    Nephrol Dial Transplant; 2018 May; 33(5):881-889. PubMed ID: 29342279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.
    Hibberd AD; Trevillian PR; Wlodarczyk JH; Kemp DG; Stein AM; Gillies AH; Heer MK; Sheil AG
    Transplantation; 2013 Jan; 95(1):122-7. PubMed ID: 23238532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplant malignancy: a burdensome complication in renal allograft recipients in Korea.
    Kim JH; Kim SO; Han DJ; Park SK
    Clin Transplant; 2014 Apr; 28(4):434-42. PubMed ID: 24750289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study.
    Holland-Bill L; Christiansen CF; Farkas DK; Donskov F; Jørgensen JOL; Sørensen HT
    Acta Oncol; 2018 Apr; 57(4):522-527. PubMed ID: 28920509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
    Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
    Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
    Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
    Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.